Skip to main content
. 2009 Apr 14;100(8):1287–1291. doi: 10.1038/sj.bjc.6605022

Figure 4.

Figure 4

Antiproliferative effects of doxorubicin (ADR) against B16-BL6 murine melanoma. Doxorubicin sensitive (Sen) and resistant (Res) sublines of B16-BL6 were treated with doxorubicin in vitro and growth was assessed after 4 days. Negative values on the y-axis indicate death of initially plated cells (n=8 each dose).